%0 Journal Article
%T Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design
%A Alison M. Betts
%A Chethana Kulkarni
%A K. Dane Wittrup
%A Katie F. Maass
%J Archive of "The AAPS Journal".
%D 2016
%R 10.1208/s12248-016-9892-3
%K antibody-drug conjugate
%K cellular trafficking
%K pharmacokinetics/pharmacodynamics
%K T-DM1
%K trastuzumab emtansine
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256610/